Drug Trends General
Key findings from the ‘Australians’ Drug Use: Adapting to Pandemic Threats’ (ADAPT) Study Wave 2
Trends in drug-related hospitalisations in Australia, 1999-2018
Use of illegal substances (e.g., heroin) and of medicines outside the bounds of a doctor’s prescription (e.g., pharmaceutical opioids) can lead to a range of harms.
Alprazolam use among a sample of people who inject drugs: Trends five years post regulatory rescheduling
Alprazolam is a high potency triazolobenzodiazepine that is approved in Australia for the treatment of anxiety and panic disorders, however, is associated with a disproportionate amount of harm com
Studying trends in fatal and non-fatal overdose: Findings from Drug Trends 2019
This presentation gives an overview of fatal and non-fatal overdose from the 2019 Drug Trends data, including naloxone knowledge and training of the IDRS sample.
Drug checking and other harm reduction behaviours reported by people who use ecstasy: Findings from the Ecstasy and Related Drugs Reporting System 2019
People who use drugs are encouraged to employ harm reduction strategies to reduce risk of acute adverse effects.
Australian Drug Trends 2015: Findings from the IDRS and the EDRS
This handout has the key findings from the 2015 IDRS and EDRS presented at the National Drug Trends Conference
Trends in Drug Use and Related Harms in Australia, 2001 to 2013: Tobacco executive summary
This is an executive summary of trends in tobacco use and related harms in Australia, 2001-2013.
Trends in Drug Use and Related Harms in Australia, 2001 to 2013: Pharmaceutical opioids executive summary
This is an executive summary of trends in pharmaceutical opioid use and related harms in Australia, 2001-2013.
Trends in Drug Use and Related Harms in Australia, 2001 to 2013: New psychoactive substances executive summary
This is an executive summary of trends in use of new psychoactive substances and related harms in Australia, 2001-2013.